Hybrid Continuous-Flow Total Artificial Heart.

TitleHybrid Continuous-Flow Total Artificial Heart.
Publication TypeJournal Article
Year of Publication2018
AuthorsFox C, Chopski S, Murad N, Allaire P, Mentzer R, Rossano J, Arabia F, Throckmorton A
JournalArtif Organs
Volume42
Start Page500
Issue5
Pagination500-509
Date Published2018 May
ISSN1525-1594
Abstract

Clinical studies using total artificial hearts (TAHs) have demonstrated that pediatric and adult patients derive quality-of-life benefits from this form of therapy. Two clinically-approved TAHs and other pumps under development, however, have design challenges and limitations, including thromboembolic events, neurologic impairment, infection risk due to large size and percutaneous drivelines, and lack of ambulation, to name a few. To address these limitations, we are developing a hybrid-design, continuous-flow, implantable or extracorporeal, magnetically-levitated TAH for pediatric and adult patients with heart failure. This TAH has only two moving parts: an axial impeller for the pulmonary circulation and a centrifugal impeller for the systemic circulation. This device will utilize the latest generation of magnetic bearing technology. Initial geometries were established using pump design equations, and computational modeling provided insight into pump performance. The designs were the basis for prototype manufacturing and hydraulic testing. The study results demonstrate that the TAH is capable of delivering target blood flow rates of 1-6.5 L/min with pressure rises of 1-92 mm Hg for the pulmonary circulation and 24-150 mm Hg for the systemic circulation at 1500-10 000 rpm. This initial design of the TAH was successful and serves as the foundation to continue its development as a novel, more compact, nonthrombogenic, and effective therapeutic alternative for infants, children, adolescents, and adults with heart failure.

DOI10.1111/aor.13080
Alternate JournalArtif Organs
PubMed ID29349805